Xiling Shen (Xilis)
A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision oncology
As Duke professor Xiling Shen tells it, the idea for his new biotech Xilis dates all the way back to 2009. Shen taught at Cornell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
